Cambridge's BIND Therapeutics (BIND) Files for Chapter 11 and Reviews Strategic Alternatives
Bay State Startup Homology Medicines Emerges with $43.5 Million and a Former Shire (SHPG) Scientist at Its Helm
EMD Serono Expansion to Create 150 New Jobs in Massachusetts
Smiths Group, Fresenius SE Rumored to Bid for Pfizer (PFE)'s $2 Billion Pump and Devices Biz Inherited from Hospira
Federal Judge Reopens Gilead (GILD) Case Amid Allegations Former Merck & Co. (MRK) Scientist Lied
Valeant (VRX) Seeks Fresh Start with Board Shakeup
FDA Clears Acadia (ACAD)'s NUPLAZID, the First Drug for Psychosis Linked to Parkinson's
Regeneron (REGN)'s Fasinumab Meets Goals in Mid-Stage Osteoarthritis Pain Study
AstraZeneca PLC (AZN) to Cut Jobs in $1.5 Billion Cost-Cutting Move, Will Double Down on Cancer
Sienna Biopharma Launches with $34 Million and a Roster Full of Former Kythera (KYTH) Execs
Medivation (MDVN) Says No! to Sanofi (SNY)'s $9.3 Billion Hostile Bid
AstraZeneca PLC (AZN) Stays Mum on M&A, Says “No Comment” to Medivation (MDVN) Bid
Abbott (ABT) Tries to Back Out of $5.8B Alere (ALR) Deal, But Alere Says It’s Still On
Life Science Real Estate Developer Lands $310 Million Construction Loan for Cambridge R&D Project
Vertex (VRTX) CEO Took a 23% Pay Cut in 2015 as Firm Overhauls Compensation Policies
FDA Sued for Not Disclosing More Info on the Experts Determining the Fate of Drugs and Devices
Allied Minds and Bristol-Myers Squibb (BMY) Throw Another $100 Million into the Development of 10 Drugs
AbbVie (ABBV) Pays $5.8 Billion+ for Bay Area's Stemcentrx, Which Has Ties to Paypal and SpaceX Investors
See All News >
AbbVie (ABBV) Pays $5.8 Billion+ for Bay Area's Stemcentrx, Which Has Ties to Paypal and SpaceX Investors
Abbott (ABT)'s $25 Billion Bid for St. Jude Medical (STJ) Raises Questions About Pending Alere (ALR) Deal
Sanofi (SNY) Makes Hostile $9.3 Billion Bid for Bay Area’s Medivation (MDVN)
Biogen (BIIB) Poaches Star Pfizer (PFE) Scientist as New R&D Chief
NantKwest CEO's $329.7 Million Pay Package Might Make Him the Highest-Paid U.S. Executive
Alnylam (ALNY) Breaks Ground on New $200 Million Manufacturing Facility in Massachusetts, Adding 150 Jobs
C-Suite Shakeup at United Therapeutics (UTHR) as Co-CEO and COO Step Down
Pennsylvania’s Inovio Pharma (INO) Doubles Workforce, Continues Hiring Spree
Anavex (AVXL)’s Alzheimer’s Drug a Possible Game Changer After Patients Reported Remarkable Positive Response
BioPharm Executive: Biotech Is for the 1%
Pfizer (PFE) to Cough Up $784.6 Million to Resolve Wyeth (WYE) False Claims Lawsuit
Valeant (VRX)'s New CEO Will Make Over $500 Million if Stock Hits $270 By 2020
Backed by Celgene (CELG), Bay Area Startup FLX Bio Bags $50 Million to Push Lead Drug into Clinic
Federal Health Regulators Release Lightly Redacted Theranos Report with More Details
Get Fit In 60 Seconds? 1-Minute Workout May Be Good Enough, McMaster University Study
What It’s Like Being A Human Lab Rat in Clinical Trials For Pharma Companies
Gene Therapy Might Be The Best And Only Chance At Curing Brain Diseases
The M&A Rumor Mill Points to Gilead (GILD) Acquiring Intercept Pharma (ICPT)
See All News >